Drugs / norethindrn a-e estradiol-iron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04899778 | Sep 2021 → Nov 2023 | ligament disorder | Cedars-Sinai Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | norethindrn a-e estradiol-iron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04899778 ↗ |
| Route | Oral | “Oral Contraceptive Pill” NCT04899778 ↗ |